JP2025512995A5 - - Google Patents
Info
- Publication number
- JP2025512995A5 JP2025512995A5 JP2024559421A JP2024559421A JP2025512995A5 JP 2025512995 A5 JP2025512995 A5 JP 2025512995A5 JP 2024559421 A JP2024559421 A JP 2024559421A JP 2024559421 A JP2024559421 A JP 2024559421A JP 2025512995 A5 JP2025512995 A5 JP 2025512995A5
- Authority
- JP
- Japan
- Prior art keywords
- compound
- pharmaceutically acceptable
- acceptable salt
- compound according
- alkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263328611P | 2022-04-07 | 2022-04-07 | |
| US63/328,611 | 2022-04-07 | ||
| US202363439645P | 2023-01-18 | 2023-01-18 | |
| US63/439,645 | 2023-01-18 | ||
| PCT/US2023/017817 WO2023196556A1 (en) | 2022-04-07 | 2023-04-07 | Cannabinoid receptor 1 antagonists/inverse agonists and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025512995A JP2025512995A (ja) | 2025-04-22 |
| JP2025512995A5 true JP2025512995A5 (https=) | 2026-04-14 |
Family
ID=88243528
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024559421A Pending JP2025512995A (ja) | 2022-04-07 | 2023-04-07 | カンナビノイド受容体１アンタゴニスト／インバースアゴニスト及びその使用 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20250248973A1 (https=) |
| EP (1) | EP4504179A4 (https=) |
| JP (1) | JP2025512995A (https=) |
| KR (1) | KR20250008741A (https=) |
| CN (1) | CN119325378A (https=) |
| AU (1) | AU2023250955A1 (https=) |
| CA (1) | CA3255170A1 (https=) |
| GB (1) | GB2633943A (https=) |
| IL (1) | IL315945A (https=) |
| MX (1) | MX2024012263A (https=) |
| WO (1) | WO2023196556A1 (https=) |
| ZA (1) | ZA202407552B (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025040089A1 (zh) * | 2023-08-21 | 2025-02-27 | 德睿智药(苏州)新药研发有限公司 | 用于选择性调节大麻素cb1功能的新型杂环类化合物 |
| WO2025103493A1 (zh) * | 2023-11-16 | 2025-05-22 | 西藏海思科制药有限公司 | 一种大麻素受体1拮抗剂及其应用 |
| WO2025185689A1 (zh) * | 2024-03-08 | 2025-09-12 | 成都轻胜生物医药科技有限公司 | 吡唑衍生物及其用途 |
| CN118580162A (zh) * | 2024-05-27 | 2024-09-03 | 中国药科大学 | 一种酰肼类化合物及无金属策略促进酰肼类化合物制备的方法 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL363751A1 (en) * | 2001-03-22 | 2004-11-29 | Solvay Pharmaceuticals B.V. | 4,5-dihydro-1h-pyrazole derivatives having cb1-antagonistic activity |
| US7655685B2 (en) * | 2007-11-02 | 2010-02-02 | Jenrin Discovery, Inc. | Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes |
| US8580768B2 (en) * | 2010-11-18 | 2013-11-12 | Jenrin Discovery, Inc. | Cannabinoid receptor antagonists-inverse agonists useful for treating metabolic disorders, including obesity and diabetes |
| KR20150113762A (ko) * | 2014-03-31 | 2015-10-08 | 한미약품 주식회사 | 황 작용기를 포함하는 4,5-다이하이드로-1h-피라졸-3-카복스이미드아마이드 유도체, 이의 제조방법 및 이를 포함하는 약학 조성물 |
| EP3109237A1 (en) * | 2015-06-22 | 2016-12-28 | AnaMar AB | Novel 5-ht2 antagonists |
| US12286405B2 (en) * | 2019-05-17 | 2025-04-29 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Scalable synthesis of dual-target inhibitor of cannabinoid-1 receptor and inducible nitric oxide synthase |
-
2023
- 2023-04-07 KR KR1020247036964A patent/KR20250008741A/ko active Pending
- 2023-04-07 EP EP23785417.9A patent/EP4504179A4/en active Pending
- 2023-04-07 US US18/854,216 patent/US20250248973A1/en active Pending
- 2023-04-07 CN CN202380045595.XA patent/CN119325378A/zh active Pending
- 2023-04-07 AU AU2023250955A patent/AU2023250955A1/en active Pending
- 2023-04-07 CA CA3255170A patent/CA3255170A1/en active Pending
- 2023-04-07 IL IL315945A patent/IL315945A/en unknown
- 2023-04-07 GB GB2416413.9A patent/GB2633943A/en active Pending
- 2023-04-07 WO PCT/US2023/017817 patent/WO2023196556A1/en not_active Ceased
- 2023-04-07 JP JP2024559421A patent/JP2025512995A/ja active Pending
-
2024
- 2024-10-03 MX MX2024012263A patent/MX2024012263A/es unknown
- 2024-10-04 ZA ZA2024/07552A patent/ZA202407552B/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2025512995A5 (https=) | ||
| JP7581192B2 (ja) | アンドロゲン受容体モジュレーター及びその使用方法 | |
| JP2023513272A5 (https=) | ||
| US8778955B2 (en) | Indole derivatives or benzimidazole derivatives for modulating IkB kinase | |
| US9162994B2 (en) | 1,2,4-thiazoloidin-3-one derivatives and their use in the treatment of cancer | |
| CN101842013B (zh) | 可用于治疗包括肥胖症和糖尿病的代谢疾患的大麻素受体拮抗剂/逆激动剂 | |
| TWI433672B (zh) | 吲唑化合物 | |
| EA016887B1 (ru) | ЗАМЕЩЁННЫЕ ФЕНОКСИАМИНОТИАЗОЛОНЫ В КАЧЕСТВЕ МОДУЛЯТОРОВ РОДСТВЕННОГО ЭСТРОГЕНОВОМУ РЕЦЕПТОРУ РЕЦЕПТОРА-α | |
| US20120322814A1 (en) | Methods of inhibiting ire1 | |
| JP2010077131A (ja) | アゾリル基を有するキノリン誘導体およびキナゾリン誘導体 | |
| JP2000086657A (ja) | ５−アミノイソキサゾール誘導体 | |
| JP5642074B2 (ja) | １−（４−ウレイドベンゾイル）ピペラジン誘導体 | |
| GB2633943A (en) | Cannabinoid receptor 1 antagonists/inverse agonists and uses thereof | |
| TW201127825A (en) | (1,1,1,3,3,3-hexafluoro-2-hydroxypropan-2-yl)phenyl derivatives | |
| JP2023516714A (ja) | 新規ｅｐ４拮抗薬の合成及びその癌及び炎症における使用 | |
| US20070149514A1 (en) | Indole-phenylsulfonamide derivatives used as ppar-delta activating compounds | |
| FR2934995A1 (fr) | Composes d'azetidines polysubstitues, leur preparation et leur application en therapeutique | |
| WO2010086613A1 (en) | Compounds useful as inhibitors as ampk | |
| CN106660968B (zh) | 吡唑衍生物及其作为大麻素受体介体的用途 | |
| JPWO2001036402A1 (ja) | 新規な２−（ｎ−シアノイミノ）チアゾリジン−４−オン誘導体 | |
| CN101478989A (zh) | 炎性肠病的处置剂 | |
| JP2011500632A (ja) | Ｎｐｙｙ２受容体モジュレーターとして有用なイミダゾリジン−２，４−ジオン（ヒダントイン）誘導体 | |
| JP2023513017A5 (ja) | カンナビノイド受容体部分アゴニストとしてのインダゾール誘導体 | |
| US6159974A (en) | LDL receptor gene expression promoters | |
| CN102413694A (zh) | 可用作faah调节剂和faah成像剂的咪唑衍生物 |